|
5.24 Pentostatin, Alemtuzumab, and Low-Dose Rituximab Is Effective Therapy for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
|
|
|
Title: |
5.24 Pentostatin, Alemtuzumab, and Low-Dose Rituximab Is Effective Therapy for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
Author: |
Zent, Clive S. LaPlant, Betsy R. Link, Brian Call, Timothy G. Shanafelt, Tait D. Bowen, Deborah A. Kay, Neil E. Weiner, George Witzig, Thomas |
Appeared in: |
Clinical lymphoma myeloma and leukemia |
Paging: |
Volume 11 (2011) nr. S2 pages 2 p. |
Year: |
2011 |
Contents: |
|
Publisher: |
Elsevier Inc. |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|